Artificial Intelligence - AI

  1. 24 Jan 2022  |  North America  |  Market Research

    Global CT Equipment Procedure Volumes and Reimbursement Growth Opportunities

    Demand for Pulmonary and Abdomen-based Imaging Accelerating the Growth of CT Procedures

    An estimated 375 million computed tomography (CT) procedures are carried out globally, increasing at 3% to 4% every year. While the COVID-19 pandemic in 2020 led to a drop in CT procedures by over 20%, the industry is expected to be completely functional by the end of 2021. Pandemic-based sanitization protocols and patient hesitancy remain restrain...

    $2,450.00
  2. 31 Jan 2022  |  North America  |  Market Research

    Global Digital Health Investments Growth Opportunities

    On-demand Healthcare Services and AI-enabled Care Delivery Enable Future Growth Potential

    Frost & Sullivan observed a significant increase in the digital transformation of healthcare and demand for effective IT solutions to improve care delivery, creating a lot of excitement among investors. Venture capitalist activities in health technology rise as healthcare organizations, clinical trial providers, insurance firms, employers, and poli...

    $2,450.00
  3. 07 Feb 2022  |  North America  |  Market Research

    Growth Opportunities for Global Computer-aided Diagnosis (CAD) in Breast Cancer Screening

    Artificial Intelligence and Deep Learning Support Better Clinical Outcomes and Fuel Growth Pipeline

    This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due ...

    $4,950.00
  4. 16 Feb 2022  |  North America  |  Market Research

    Global Molecular Imaging (MI) Equipment Growth Opportunities

    Development of Novel Radiopharmaceuticals and Technical Advancements in AI and Hybrid Systems Fuel the Growth Pipeline

    This research study presents an analysis of and growth opportunities for the global molecular imaging (MI) equipment market. It offers an in-depth analysis of the current trends, market size, revenue forecast (2022–2026), and market penetration of PET/CT, PET/MRI, SPECT, and SPECT/CT systems. Each year, more than 36 million MI procedures are p...

    $4,950.00
  5. 22 Feb 2022  |  North America  |  Market Research

    Global Molecular Imaging Procedures Growth Opportunities

    The Development of Novel Radiopharmaceuticals and the Expanding Clinical Applications for Molecular Imaging Equipment will Create Opportunities for the Growth of Procedures

    This Frost & Sullivan research service presents an analysis of the global molecular imaging (MI) procedures market and an overview of the development of novel radiopharmaceuticals. It offers an in-depth analysis of current trends and a forecast for PET/CT and SPECT/CT procedures. The study also outlines healthcare infrastructure and MI procedure vo...

    $2,450.00
  6. 08 Mar 2022  |  North America  |  Market Research

    US Clinical Decision Support System (CDSS) Growth Opportunities

    Sparking Future Growth Potential for Health Data, AI, and SDoH to Increase Accuracy and Efficiency among Providers and Payers and Improve the Patient Journey

    Clinical decision support (CDS) is a broad concept with many definitions that are used variably, depending on the perspective and role of the expert. It includes a mix of evidence (content), analytics, workflow, devices, and software-based solutions that must include electronic health records (EHRs) and be maintained by an IT platform. This repo...

    $4,950.00
  7. 14 Mar 2022  |  North America  |  Market Outlook

    Next-generation Diagnostics Outlook, 2022

    Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth

    In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...

    $4,950.00
  8. 23 Mar 2022  |  North America  |  Market Outlook

    Global Digital Health Outlook, 2022

    Innovative Business Models of Remote Patient Monitoring Solutions Go beyond Chronic Care Management and Across the Care Continuum

    Digital health offered extensive support and grew stronger as the pandemic continued with several variants across the globe. Telehealth and other enterprise IT solutions continued to be the backbone for healthcare systems, and access to health in the hands of the patients empowered consumers to manage their health with the best of tools. As the dem...

    $4,950.00
  9. 01 Apr 2022  |  North America  |  Market Outlook

    Global Medical Imaging and Informatics Outlook, 2022

    Smart Manufacturing and Cloud-based AI Solutions will Drive Market Growth and the Efficiency of Medical Imaging and Informatics

    The global medical imaging and informatics market is experiencing significant changes with the emergence of advanced technologies, the changing consumer landscape and priorities, consolidation among radiology practices, mergers and acquisitions, portability, regulatory and reimbursement changes, smart manufacturing, local and global manufacturing, ...

    $4,950.00
  10. 25 Apr 2022  |  North America  |  Frost Radar

    Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...

    $4,950.00